216 related articles for article (PubMed ID: 29652514)
21. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
[TBL] [Abstract][Full Text] [Related]
22. A functional NQO1 609C>T polymorphism and risk of gastrointestinal cancers: a meta-analysis.
Yu H; Liu H; Wang LE; Wei Q
PLoS One; 2012; 7(1):e30566. PubMed ID: 22272361
[TBL] [Abstract][Full Text] [Related]
23. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians.
Zhang Y; Wang ZT; Zhong J
Genet Mol Res; 2012 Aug; 11(3):2328-37. PubMed ID: 22911602
[TBL] [Abstract][Full Text] [Related]
25. The NQO1 C609T polymorphism and hepatocellular carcinoma risk.
Fan Y; Hu D; Feng B; Wang W
Tumour Biol; 2014 Aug; 35(8):7343-50. PubMed ID: 24532470
[TBL] [Abstract][Full Text] [Related]
26. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
28. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the MTHFR C677T Polymorphism as a Risk Factor for Colorectal Cancer in Asian Populations.
Rai V
Asian Pac J Cancer Prev; 2015; 16(18):8093-100. PubMed ID: 26745044
[TBL] [Abstract][Full Text] [Related]
30. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
31. Effect of NQO1 C609T polymorphism on prostate cancer risk: a meta-analysis.
Zhang Q; Zheng M; Qi XL; Liu F; Mao ZJ; Zhang DH
Onco Targets Ther; 2014; 7():907-14. PubMed ID: 24940075
[TBL] [Abstract][Full Text] [Related]
32. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population.
Zhao H; Zou LW; Zheng SS; Geng XP
Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831
[TBL] [Abstract][Full Text] [Related]
33. The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study.
Yadav P; Mir R; Nandi K; Javid J; Masroor M; Ahmad I; Zuberi M; Kaza R; Jain S; Khurana N; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2016; 17(3):1215-9. PubMed ID: 27039751
[TBL] [Abstract][Full Text] [Related]
34. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
[TBL] [Abstract][Full Text] [Related]
35. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
36. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk.
Wang Z; Hu J; Zhong J
DNA Cell Biol; 2012 Apr; 31(4):560-7. PubMed ID: 22017531
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
Zhao H; Zhu F; Sun J; Meng X
Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
[TBL] [Abstract][Full Text] [Related]
39. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
40. Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.
Diao J; Bao J; Peng J; Mo J; Ye Q; He J
Ther Adv Med Oncol; 2017 Jan; 9(1):13-21. PubMed ID: 28203294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
